Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)

NCT00757029 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity
Methylphenidate
Pharmacogenetics

Interventions

GENETIC: norepinephrine transporter polymorphism,

Sponsor

Hallym University Medical Center